{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:50:27Z","timestamp":1793854227733,"version":"4.6.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81360595"],"award-info":[{"award-number":["81360595"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81160433"],"award-info":[{"award-number":["81160433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2013GXNSFBA019188"],"award-info":[{"award-number":["2013GXNSFBA019188"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.yexcr.2017.02.038","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:30:59Z","timestamp":1487917859000},"page":"420-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Modulation of hepatic stellate cells and reversibility of hepatic fibrosis"],"prefix":"10.1016","volume":"352","author":[{"given":"Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2017.02.038_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis-from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.46.4.443","article-title":"Is liver fibrosis reversible?","volume":"46","author":"Benyon","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.yexcr.2017.02.038_bib3","first-page":"26617169","article-title":"Cirrhosis and liver fibrosis are potentially reversible","volume":"177","author":"Hansen","year":"2015","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.yexcr.2017.02.038_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1089-3261(05)70168-9","article-title":"Hepatic fibrosis. Pathogenesis and principles of therapy","volume":"5","author":"Albanis","year":"2001","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.yexcr.2017.02.038_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.yexcr.2017.02.038_bib6","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: the principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2017.02.038_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.1994.tb17259.x","article-title":"The extracellular matrix in cellular proliferation and differentiation","volume":"733","author":"Schuppan","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.yexcr.2017.02.038_bib8","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1357-2725(96)00118-5","article-title":"Tissue inhibitors of metalloproteinases in liver fibrosis","volume":"29","author":"Iredale","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbadis.2012.11.002","article-title":"Extracellular matrix degradation in liver fibrosis: biochemistry and regulation","volume":"1832","author":"Iredale","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2017.02.038_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2001-17555","article-title":"Interactions between hepatic stellate cells and the immune system","volume":"21","author":"Maher","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.yexcr.2017.02.038_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hep.1840380418","article-title":"Hepatology. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation","volume":"38","author":"Vi\u00f1as","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.1840080508","article-title":"Lipocytes and transitional cells in alcoholic liver disease: a morphometric study","volume":"8","author":"Mak","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib14","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI114886","article-title":"Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo","volume":"86","author":"Maher","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2017.02.038_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.1840100117","article-title":"In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells","volume":"10","author":"Milani","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib16","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/hep.25567","article-title":"Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase(MMP-12) during experimental liver fibrosis","volume":"55","author":"Pellicoro","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hep.510240129","article-title":"Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis","volume":"24","author":"Iredale","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hep.510240129","article-title":"Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis","volume":"24","author":"Iredale","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib20","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.clinre.2015.06.015","article-title":"Reversibility of liver fibrosis","volume":"39","author":"Sun","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib21","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib22","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1074\/jbc.M111490200","article-title":"Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis","volume":"277","author":"Murphy","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2017.02.038_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0016-5085(00)70370-2","article-title":"An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis","volume":"118","author":"Cho","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/hepr.12582","article-title":"Evaluation of neutrophil\/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event","volume":"46","author":"Agiasotelli","year":"2016","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.yexcr.2017.02.038_bib25","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1097\/MCG.0000000000000162","article-title":"Cirrhosis regression in patients with viral hepatitis B and C: a systematic review","volume":"48","author":"Manne","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jceh.2013.05.007","article-title":"Reversibility of hepatic fibrosis and cirrhosis-another evidence","volume":"3","author":"Duseja","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.gastrohep.2010.04.007","article-title":"Reversibility of hepatitis B virus-induced liver cirrhosis after prolonged antiviral therapy","volume":"33","author":"P\u00e9rez Rold\u00e1n","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib28","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","volume":"344","author":"Hammel","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40139-013-0018-7","article-title":"Reversibility of Liver Fibrosis and inactivation of fibrogenic myofibroblasts","volume":"1","author":"Liu","year":"2013","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.yexcr.2017.02.038_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1089-3261(02)00076-4","article-title":"Approaches for treatment of liver fibrosis in chronic hepatitis C","volume":"7","author":"Bedossa","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.yexcr.2017.02.038_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.biopha.2012.10.002","article-title":"Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential","volume":"67","author":"Kong","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2017.02.038_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jhep.2013.03.031","article-title":"Reversion of hepatic stellate cell to a quiescent phenotype: from myth to reality?","volume":"59","author":"Mallat","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/gut.2005.090449","article-title":"Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease","volume":"55","author":"Kawada","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.yexcr.2017.02.038_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0006-2952(03)00403-9","article-title":"Inhibition of markers of hepatic stellate cell activation by the hormone relaxin","volume":"66","author":"Bennett","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2015.10.101","article-title":"Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model","volume":"469","author":"Karthikeyan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2017.02.038_bib37","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2017.02.038_bib38","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0168-8278(01)00212-4","article-title":"Plasminogen deficiency results in poor clearance of non-fibrin matrix and persistent activation of hepatic stellate cells after an acute injury","volume":"35","author":"Ng","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib40","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2017.02.038_bib41","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.3748\/wjg.v21.i17.5138","article-title":"Reversibility and heritability of liver fibrosis: implications for research and therapy","volume":"21","author":"Atta","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib42","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2017.02.038_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","article-title":"Natural killer and natural killer T cells in liver fibrosis","volume":"1832","author":"Gao","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2017.02.038_bib46","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/hep.27392","article-title":"IL-30(IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice","volume":"60","author":"Mitra","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib47","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib48","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib50","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/gut.48.4.548","article-title":"Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors","volume":"48","author":"Issa","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.yexcr.2017.02.038_bib51","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2005.082701","article-title":"Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans","volume":"55","author":"Novo","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.yexcr.2017.02.038_bib52","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1440-1746.2006.04584.x","article-title":"Hepatic stellate cells and the reversal of fibrosis","volume":"21","author":"Kisseleva","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2789245","article-title":"Modulation of Bcl-x alternative splicing induces apoptosis of human hepatic stellate cells","volume":"2016","author":"Wu","year":"2016","journal-title":"Biomed. Res Int."},{"key":"10.1016\/j.yexcr.2017.02.038_bib54","doi-asserted-by":"crossref","DOI":"10.1139\/cjpp-2015-0284","article-title":"Modified citrus pectin stops progression of liver fibrosis by inhibiting galectin-3 and inducing apoptosis of stellate cells","volume":"94","author":"Abu-Elsaad","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/734987","article-title":"Explore the molecular mechanism of apoptosis induced by tanshinone IIA on activated rat hepatic stellate cells","volume":"2012","author":"Pan","year":"2012","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2017.02.038_bib57","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1038\/srep09713","article-title":"Potent effects of dioscin against liver fibrosis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2017.02.038_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1742-7843.2009.00465.x","article-title":"Tanshinone II A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells","volume":"106","author":"Che","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2893.2008.01052.x","article-title":"Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection","volume":"16","author":"Gonzalez","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.yexcr.2017.02.038_bib60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-2005-837757","article-title":"Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro","volume":"71","author":"Park","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-2005-871280","article-title":"Skullcapflavone I from Scutellaria baicalensis induces apoptosis in activated rat hepatic stellate cells","volume":"71","author":"Park","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2017.02.038_bib63","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.exger.2003.07.002","article-title":"Hepatic sinusoidal pseudocapillarization with aging in the non-human primate","volume":"38","author":"Cogger","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-016-0438-x","article-title":"Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings","author":"Panebianco","year":"2016","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib65","doi-asserted-by":"crossref","first-page":"231ra47","DOI":"10.1126\/scitranslmed.3008182","article-title":"Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance","volume":"6","author":"Hecker","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1101\/gad.235184.113","article-title":"Cellular senescence and its effector programs","volume":"28","author":"Salama","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2017.02.038_bib67","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/MCB.00049-13","article-title":"Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts","volume":"33","author":"Kim","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/mol.107.039818","article-title":"Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation","volume":"73","author":"Fu","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib69","first-page":"172","article-title":"Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells","volume":"49","author":"Lu","year":"2002","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.yexcr.2017.02.038_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2007.10.003","article-title":"Activity and expression of ecto-5'-nucleotidase\/CD73 are increased during phenotype conversion of a hepatic stellate cell line","volume":"82","author":"Andrade","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.yexcr.2017.02.038_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13069-015-0031-z","article-title":"In vitro reversion of activated primary human hepatic stellate cells","volume":"8","author":"Taghdouini","year":"2015","journal-title":"Fibrogenes. Tissue Repair."},{"key":"10.1016\/j.yexcr.2017.02.038_bib72","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejphar.2013.09.067","article-title":"Fructose-1,6-bisphosphate induces phenotypic reversion of activated hepatic stellate cell","volume":"720","author":"de Mesquita","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/TP.0000000000000461","article-title":"Modulating CD4+ T cell migration in the postischemic liver: hepatic stellate cells as new therapeutic target?","volume":"99","author":"Reifart","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.yexcr.2017.02.038_bib74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fimmu.2016.00019","article-title":"Natural killer cells and liver fibrosis","volume":"7","author":"Fasbender","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib75","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/labinvest.2012.54","article-title":"cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner","volume":"92","author":"Gl\u00e4ssner","year":"2012","journal-title":"Lab Invest."},{"key":"10.1016\/j.yexcr.2017.02.038_bib76","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/jpet.111.179820","article-title":"Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of \u03baB kinase \u03b1\/inhibitor of \u03baB-\u03b1\/nuclear factor-\u03baB pathway","volume":"339","author":"Ping","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexcr.2017.02.038_bib77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis","volume":"10","author":"Elsharkawy","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2017.02.038_bib78","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1038\/srep34605","article-title":"IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner","volume":"6","author":"Nishizawa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2017.02.038_bib79","doi-asserted-by":"crossref","first-page":"e2189","DOI":"10.1038\/cddis.2016.92","article-title":"Activation of PPAR\u03b3\/P53 signaling is required for curcumin to induce hepatic stellate cell senescence","volume":"7","author":"Jin","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2017.02.038_bib80","doi-asserted-by":"crossref","first-page":"30957","DOI":"10.1038\/srep30957","article-title":"Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3\/p53\/p21 pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2017.02.038_bib81","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib82","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrgastro.2013.244","article-title":"Liver: hepatic stellate cells hold the key to liver fibrosis","volume":"11","author":"Ray","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2017.02.038_bib83","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s12072-016-9758-x","article-title":"Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key","volume":"10","author":"Bansal","year":"2016","journal-title":"Hepatol. Int."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717300927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482717300927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T17:17:01Z","timestamp":1719076621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482717300927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0014482717300927"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.02.038","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of hepatic stellate cells and reversibility of hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2017.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}